Yan Zeng - Lotus Pharmaceuticals CFO and Principal Accounting Officer
| LTUS Stock | USD 0.0009 0.0001 12.50% |
CFO
Ms. Zeng Yan is Chief Financial Officer of Lotus Pharmaceuticals Inc. She has over ten years experience as a financial manager and auditor for Chinese based companies. From September 3, 2010 to September 21, 2010, Ms. Zeng served as an accountant for Beijing Liang Fang Pharmaceutical Ltd.. From May 1, 2009 to September 2, 2010, Ms. Zeng served as Chief Financial Officer of Lotus Pharmaceuticals, Inc.. From 2008 to April 30, 2009, Ms. Zeng was an accountant for Beijing Liang Fang Pharmaceutical Ltd., a subsidiary of Lotus Pharmaceuticals, Inc.. From 2005 to 2008, Ms. Zeng was a registered accountant in Beijing Topson Certified Public Accountants, where she conducted auditing and provided financial counsel for public companies. From 2004 to 2005, Ms. Zeng was a financial manager for Beijing Unite Youbang Science and Technology Ltd since 2010.
| Age | 54 |
| Tenure | 14 years |
| Professional Marks | CPA |
| Phone | 615 310 2688 |
| Web | https://lotuspharmaceuticalsusa.com |
Lotus Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0456 % which means that it generated a profit of $0.0456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0182 %, meaning that it created $0.0182 on every $100 dollars invested by stockholders. Lotus Pharmaceuticals' management efficiency ratios could be used to measure how well Lotus Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | CFO Age | ||
| Colette Kress | NVIDIA | 57 | |
| Amy Hood | Microsoft | 52 | |
| Sarah Youngwood | Nasdaq Inc | 50 | |
| David Fallon | Vertiv Holdings Co | 55 | |
| Dominic Dragisich | Choice Hotels International | 41 | |
| Jamie Miller | PayPal Holdings | 55 | |
Management Performance
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0456 |
Lotus Pharmaceuticals Management Team
Elected by the shareholders, the Lotus Pharmaceuticals' board of directors comprises two types of representatives: Lotus Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lotus. The board's role is to monitor Lotus Pharmaceuticals' management team and ensure that shareholders' interests are well served. Lotus Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lotus Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xing Shen, VP of Corporate Devel. | ||
| Yan Zeng, CFO and Principal Accounting Officer | ||
| Zhong Liu, Chairman, Founder |
Lotus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Lotus Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0456 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 762.17 K | |||
| Shares Outstanding | 27.82 M | |||
| Price To Earning | 0.18 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 72.7 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lotus Pink Sheet Analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.